When cancer comes back after treatment—or doesn’t respond at all—it can feel like the options are running out. But science is moving fast, and a new therapy called Terbium-161 FAPI is offering fresh hope to patients with relapsed or refractory solid…
🌟 Terbium-161 DOTATATE: A New Option for Neuroendocrine Tumors That Resist Standard Treatment
Living with a neuroendocrine tumor (NET) can be a long journey filled with ups and downs. For many patients, Lutetium-177 DOTATATE (Lu-177 PRRT) has been a game-changer—slowing tumor growth and improving quality of life. But what happens when the tumor stops…
Terbium-161 PSMA Therapy: A New Hope for Advanced Prostate Cancer Patients Resistant to Lutetium-177 PSMA
For many men battling advanced prostate cancer, modern treatments like Lutetium-177 PSMA therapy have brought relief and extended life. But what happens when the cancer stops responding? That’s where a new therapy “Terbium-161 PSMA” is stepping in, offering fresh hope for…
India’s 1st Radium-223 Therapy for Advanced Prostate Cancer Now Available at Theranostics Centre a unit of Sarvodaya Hospital
Sarvodaya Cancer Hospital Delhi NCR proudly announces the first-time availability of Radium-223 therapy in India for patients with castration-resistant prostate cancer (CRPC) and predominant skeletal metastases. This milestone marks a new era in precision oncology, offering hope to patients with advanced…
A New Ray of Hope: Terbium-161 Therapy Now Available at Theranostics Centre a unit of Sarvodaya Hospital
Theranos Care unit of Sarvodaya Hospital, Faridabad has become the first center in the Indian subcontinent to offer Terbium-161 therapy in India for patients with metastatic castration-resistant prostate cancer (mCRPC) and metastatic neuroendocrine tumors (NET) who have not responded to Lutetium-PSMA…
Neuroendocrine Tumors: Symptoms, Causes, Risk Factors & Treatment
Neuroendocrine tumors (NETs) are a rare group of cancers that can grow in different parts of the body. They start in special cells called “neuroendocrine cells”, which help control how your body works by releasing hormones. These cells are found in…
Peptide Receptor Radionuclide Therapy PRRT Role in Neuroendocrine Cancer treatment
A Targeted Breakthrough in Treating Neuroendocrine Tumors By Using PRRT Being diagnosed with a neuroendocrine tumor (NET) can feel confusing and overwhelming. These rare tumors often grow slowly and may not cause symptoms for years. But when they do, they can…
Targeted Lu-177 (Lutetium) PSMA Therapy for Prostate Cancer: A New Hope for Men Fighting Advanced Disease
If you or a loved one is living with advanced prostate cancer, you may have heard about a new treatment called Lu-177 PSMA therapy. It’s one of the most promising breakthroughs in cancer care—and it’s changing lives by offering hope where…
Nuclear Medicine Therapy for Prostate Cancer: Options, Side Effects & Success Rates
If you or a loved one is facing advanced prostate cancer, you may have heard about new treatments using nuclear medicine or simply put, Theranostics. These therapies – Lutetium-177 (Lu-177), Actinium-225 (Ac-225), and Terbium-161 (Tb-161) – are offering new hope to…
Actinium-225 PSMA Therapy: A New Hope for Prostate Cancer Patients in India
If you or your loved one is living with advanced prostate cancer and have already tried several treatments like chemotherapy or Lutetium-177 therapy, there’s a new and promising option available: “Actinium-225 PSMA therapy”. What Is Actinium-225 Therapy? This treatment uses a…